Last checked at 
LONDON, March 19 (Reuters) - Oxford's vaccine trial chief
said on Friday it was reassuring that safety monitoring systems
were working after European Union and British regulators backed
the COVID-19 shot which the university has made with AstraZeneca
<AZN.L.
"What we really should be focusing on is that this is
incredibly reassuring. The processes are working, the safety
monitoring that we all expect from our authorities is
happening," Andrew Pollard, who runs the Oxford Vaccine Group,
told BBC radio, after both regulators said vaccinations could
continue after reports of blood clots.
"We do need to continue to monitor safety, but in the end
it's the virus we're fighting, not the vaccines."
(Reporting by Alistair Smout; editing by Sarah Young)
